FASN and colorectal carcinoma: In contrast, shRNA-mediated downregulation of FASN in primary PT130 CRC cells established in our laboratory [6] leads to a decrease in GFPT1 and OGT expression and a decrease in O-linked glycosylation (Figure 3B).